Holcombe Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$330K Sell
285
-24
-8% -$28.3K 0.18% 45
2026
Q2
$371K Buy
+309
New +$316K 0.21% 44

Other funds holding LLY

Holcombe Financial's LLY Position: Q3 2026 in Review

Holcombe Financial reduced its Eli Lilly (LLY) stake by 7.8% in Q3 2026, selling an estimated $28.3K and leaving 285 shares worth $330K. The position accounts for 0.18% of the portfolio, ranked #45.

Holcombe Financial first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $371K in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Holcombe Financial held 285 shares of Eli Lilly worth $330K as of Q3 2026.
  • Holcombe Financial sold 24 Eli Lilly shares in Q3 2026, an estimated $28.3K.
  • Eli Lilly made up 0.18% of Holcombe Financial's portfolio in Q3 2026, its #45 holding.
  • Holcombe Financial first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • Holcombe Financial's Eli Lilly position peaked at $371K in Q2 2026.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Holcombe Financial's 13F filing for Q3 2026, filed 16 Oct 2026.